Have a feature idea you'd love to see implemented?
Let us know!
ELEV Elevation Oncology Inc
Price (delayed)
$0.6241
Market cap
$36.89M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$8.36M
Highlights
The EPS has surged by 78% year-on-year and by 19% since the previous quarter
ELEV's net income has soared by 53% YoY
Elevation Oncology's quick ratio has decreased by 10% QoQ
The debt has grown by 3.8% YoY
Key stats
What are the main financial stats of ELEV
Market
Valuations
Earnings
Shares outstanding
59.11M
Market cap
$36.89M
Enterprise value
$8.36M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$39.26M
EBITDA
-$39.23M
Free cash flow
-$43.32M
Per share
Balance sheet
Liquidity
EPS
-$0.79
Free cash flow per share
-$0.73
Book value per share
$1.48
Revenue per share
$0
TBVPS
$1.94
Total assets
$114.6M
Total liabilities
$33.68M
Debt
$30.92M
Equity
$80.92M
Working capital
$110.81M
Debt to equity
0.38
Current ratio
41.1
Quick ratio
40.12
Net debt/EBITDA
0.73
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-38.5%
Return on equity
-58%
Return on invested capital
-59.6%
Return on capital employed
-35.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ELEV stock price
How has the Elevation Oncology stock price performed over time
Intraday
3.91%
1 week
13.21%
1 month
5.01%
1 year
4.03%
YTD
16.22%
QTD
4.03%
Financial performance
How have Elevation Oncology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$39.7M
Net income
-$39.7M
Gross margin
N/A
Net margin
N/A
ELEV's net income has soared by 53% YoY
Elevation Oncology's operating income has surged by 53% YoY but it has decreased by 2.9% QoQ
Growth
What is Elevation Oncology's growth rate over time
Valuation
What is Elevation Oncology stock price valuation
P/E
N/A
P/B
0.42
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 78% year-on-year and by 19% since the previous quarter
ELEV's P/B is 72% below its last 4 quarters average of 1.5
ELEV's equity is up by 12% year-on-year and by 7% since the previous quarter
Efficiency
How efficient is Elevation Oncology business performance
ELEV's ROIC has soared by 65% YoY and by 23% QoQ
The return on equity has surged by 62% year-on-year and by 2.2% since the previous quarter
Elevation Oncology's ROA has soared by 56% YoY
Dividends
What is ELEV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ELEV.
Financial health
How did Elevation Oncology financials performed over time
Elevation Oncology's total liabilities has decreased by 12% YoY
Elevation Oncology's current ratio has decreased by 11% from the previous quarter
The debt is 62% less than the equity
ELEV's equity is up by 12% year-on-year and by 7% since the previous quarter
The debt to equity has contracted by 7% from the previous quarter and by 7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.